Study of a selective kinase inhibitor entrectinib targeting NTRK, ROS1 and ALK fusion-positive solid tumors
WANG Ji-yuan
LI Liang
QIN Yan
Machine-generated Keywords：
Publication Date：2019-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：7( 2360-2366 )